Merck nears deal for rare-disease-drug maker Acceleron
September 28, 2021 at 03:20 AM EDT
Merck is in advanced talks to acquire Acceleron Pharma Inc., according to people familiar with the matter, in a move that would bolster the pharmaceutical giant’s rare-disease business.